Seven-day holter monitoring detects more significant arrhythmias than 24-hour and 3-day monitoring

Funding Acknowledgements

Type of funding sources: None.

Background/Introduction

24-hour Holter monitors have been used widely to assess patients with suspected and known arrhythmias. Recent studies have shown increased yield of arrhythmia detection with longer durations of Holter monitoring.

Purpose

The aim of the study was to evaluate the incremental yield in significant arrhythmias detected using a 7-day continuous Holter monitor, as compared to what can be achieved within a 24-hour and 48 to 72 hours study.

Methods

A retrospective study of patients from 72 sites in two geographical locations, A and B, who completed a continuous 7-days patch monitor study was performed. 801 of these studies detected significant arrhythmias; pauses 3 seconds or more (PA), ventricular tachycardia of 6 beats or more (VT), and paroxysmal atrial fibrillation (PAF). The day of the first occurrence of a significant arrhythmia was noted and tallied to determine the incremental yield of a multiday Holter monitoring.

Results

Of 801 total cases detected with significant arrhythmia, only 278 (35%) were detected in the first 24hours, while 523 (65%) cases were detected after Day 1. 331 (41%) had first significant arrhythmia detected after the 3rd day of monitoring, with 68 (44%) being PA, 125 (40%) PAF, and 138 (41%) VT. Notably, in Group A, 31 (72%) of total VT detected and 35 (72%) of total PAF detected were first picked up after Day 1, 21 (49%) of total VT were first detected only after the 3rd day of monitoring.

Conclusions

1-day (24-hour) monitoring period fails to detect a significant number of potentially serious cardiac arrhythmias. Extended continuous Holter monitoring increases the yield of detection, with a substantial fraction (40-49%) detected after the 3rd day of monitoring. No difference in results obtained between two geographical locations demonstrates strong evidence that findings are consistent across different sites. Review of current practice and guidelines is necessary to further expand usage of multiday Holter monitoring, thus increasing benefits to patients.

Unearthing the evidence: post-mortem interrogation of cardiac implantable electronic devices

Background

The diagnostic yield of post-mortem interrogation of cardiac implantable electronic devices (CIEDs) including pacemakers, defibrillators and implantable loop recorders has not been well described.

Methods

We reviewed all post-mortem CIED interrogations performed by our statewide Institute of Forensic Medicine between 2005–2020 for investigation of sudden or unexplained death.

Results

260 patients (68.8% male, median age 72.8 years [IQR 62.7–82.2]) underwent post-mortem CIED interrogation (202 pacemakers, 56 defibrillators and 2 loop recorders). CIEDs were implanted for a median of 2.0 [IQR 0.75–5] years, with 19 devices requiring replacement (and 5 end of life). Post-mortem interrogation was successful in 256 (98.5%) cases. Potential CIED malfunction was identified in 21 (8.1%) cases: untreated ventricular arrhythmias (n=13), lead failures (n=3) and battery depletion (n=5). CIED interrogation directly informed cause of death in 130 (50.0%) cases, with fatal ventricular arrhythmias identified in 121 patients (46.5%). In retrospect, 72 (27.7%) patients had abnormalities recorded by their device in the 30 days preceding death: non-sustained ventricular tachycardia (n=26), rapid atrial fibrillation (n=17), longevity concerns (n=22), intrathoracic impedance alarms (n=3), lead issues (n=3) or therapy delivered (n=1). In 6 cases where the patient was found deceased after a prolonged time, CIED interrogation accurately determined time of death. In one case, CIED interrogation was the primary method of patient identification.

Conclusion

Post-mortem CIED interrogation frequently contributes important information regarding critical device malfunction, pre-mortem abnormalities, cause and time of death or patient identity. Device interrogation should be considered for select patients with CIEDs undergoing autopsy.

Funding Acknowledgement

Type of funding sources: None.

Clinical use of nonthoracotomy cardioversion-defibrillation system

OBJECTIVE

To summarize our experience in 22 patients who had attempted nonthoracotomy implantable cardioverter-defibrillators (ICD) for malignant ventricular arrhythmias (VA).

METHODS

Indications for implantation were ventricular fibrillation (VF) in 17 patients and refractory ventricular tachycardia in 5. Thirteen patients of them had underlying ischaemic heart disease. Seven had dilated cardiomyopathy and two had arrhythmogenic right ventricular dysplasia.

RESULTS

20 out of 22 patients were successfully implanted nonthoracotomic ICD with defibrillating threshold of 16.7 J. The mean hospital stay was 7.8 days. The complications included chest wall haematoma and ventricular lead dislodgment requiring repositioning. In the follow-up period of 10.1 +/- 8 months, 6 patients with VA were treated successfully by ICD.

CONCLUSION

Nonthoracotomy ICD is possible in a vast majority of patients (91%) and should be considered in all patients requiring ICD without concomitant surgery.

Long-term performance of steroid-eluting lead in dual chamber pacing

The atrial pacing lead is believed having higher stimulation thresholds and long-term complication rates than ventricular lead, this being one of the factors limiting the use of dual chamber pacing. A prospective study was undertaken to evaluate both atrial and ventricular bipolar tined steroid-eluting leads in long-term dual chamber pacing. There are 81 pairs of leads (Medtronic Capsure SP) used in 81 patients. Bipolar atrial and ventricular stimulation thresholds were measured immediately post implantation and 1, 3, 6, 12, 18 and 24 months. All leads demonstrated low mean stimulation thresholds during the follow-up and more than 94% of leads could be paced chronically in the atrium and ventricle at 2.5 volts. In conclusion, atrial and ventricular steroid-eluting leads gave excellent stimulation thresholds allowing low energy long-term dual chamber pacing.

Permanent ventricular pacing via the great cardiac vein

Two cases of left ventricular pacing via the great cardiac vein are presented. A 64-year-old female with a mechanical prosthetic tricuspid valve and slow atrial fibrillation had a failed attempt at pacing from the middle cardiac vein. In a 58-year-old male with hypertrophic obstructive cardiomyopathy and bradycardia tachycardia syndrome, transvenous permanent pacing could not be achieved via the right ventricle or middle cardiac vein. In both cases, successful pacing via the great cardiac vein was achieved but with an elevated stimulation threshold. These cases illustrate an alternate transvenous route when difficulties occur using standard ventricular pacing sites.

Catheter ablation of the atrioventricular node using radiofrequency energy

BACKGROUND

Catheter ablation of the atrioventricular (AV) junction using stored direct current (DC) energy from a standard DC Cardioverter defibrillator was first reported in 1982. Since then many patients have been treated using this procedure for refractory supraventricular arrhythmias, usually atrial fibrillation and flutter. Undesirable thermal effects such as barotrauma and arcing are largely responsible for complications associated with the use of DC energy. This report details our experience of catheter ablation of the AV junction using radiofrequency (RF) energy in a series of 30 consecutive patients.

METHODS

RF ablations were performed using steerable Mansfield (Webster Laboratories) 4 mm tipped electrodes and locally assembled RF energy delivery system.

RESULTS

The procedure was successful in 27/30 (90%) patients using RF energy, while three patients required DC energy to achieve successful AV junction ablation. General anaesthesia was required in nine patients, six of whom required this for cardioversion to sinus rhythm so that an adequate His Bundle spike could be recorded and three for DC ablation. Dual chamber permanent pacemakers with automatic mode switching were implanted in four patients who had paroxysmal atrial fibrillation or flutter and the remainder had ventricular rate responsive pacemakers.

CONCLUSIONS

In patients with drug refractory paroxysmal atrial fibrillation and flutter and in patients with established atrial fibrillation where control of the ventricular rate is difficult, catheter ablation of the AV junction using RF energy is a safe and effective procedure with a high success rate.

"Pacecare"--a computerized database for pacemaker follow-up

A computerized database for pacemaker follow-up has been designed to run on IBM compatible hardware and to accept pulse generator and lead models of all manufacturers. Stored data includes patient, physician and implant details, indications for pacing, underlying rhythm, complications and management, program settings, and follow-up measurements. Typing is minimized by the use of "pop-up" lists and prepared pulse generator template displays. At each follow-up visit a patient's file is retrieved by surname or number, a visit record created, and measurements documented. As the template of the previous visit is used, recording of the clinic visit takes less than 1 minute. Changes in pacing rates (base or magnet), pulse widths, lead thresholds, lead impedance, and battery cell impedance can be displayed graphically for immediate recognition of end-of-life parameters or suspected malfunction. The program will print patient, implantation and clinic visit summary reports, clinic appointment lists, letters to patients, and annual reports. Two Melbourne hospitals have now entered over 3,600 patients into the database. Valuable information has been obtained regarding implantation details and trends with pulse generator and lead usage. Pacecare is a sophisticated, yet user friendly, computerized database for pacemaker follow-up. Recording of clinic visits is fast and changes in testing parameters can be recognized immediately.

Stiffness of the distal tip of bipolar pacing leads

The stiffness of a bipolar pacing lead, particularly between anode and cathode, may be responsible for myocardial penetration and perforation. Following an unprecedented 7% incidence of high threshold exit block with a single model bipolar ventricular endocardial lead, a study was undertaken to compare pacing lead stiffness between anode and cathode of six models of bipolar leads from two manufacturers; Telectronics (T) and Medtronics (M). Four leads had polyurethane insulation; T 030-284 (Laser Dish), T 329-259 (Cordis, Encor), M 4012 (Target Tip), and M 4004 (Capsure). Two leads had silicone rubber insulation; M 5026 (Capsure) and M 5024 (Capsure SP). All leads were subjected to two stiffness tests. The Tip Deflection Test involved securing the lead at 45 degrees at the indifferent electrode and applying a force to deflect the tip 5 mm. The three point bending test involved placing the lead over two fixed bars in contact with the anode and cathode. Midway a third bar was pushed onto the lead and the force to deflect the lead 2 mm was recorded. The results showed that pacing leads with polyurethane insulation were much stiffer than those with silicone rubber insulation. The T 030-284 because of its construction was found to be the stiffnest. The next stiffnest was the M 4012. Both these leads had an unacceptable incidence of high threshold exit block; 7% with the T 030-284 (89 implants) and 3% with the M 4012 (102 implants). No cases of high threshold exit block were documented with the other four pacing leads and in particular the silicone rubber M 5026 (344 implants).(ABSTRACT TRUNCATED AT 250 WORDS)

Rate responsive pacing using a minute ventilation sensor

Minute ventilation, the product of respiratory rate and tidal volume, correlates directly with oxygen consumption, cardiac output, and heart rate. An implantable pacemaker has been developed which allows variation in pacing rate in response to measured changes in minute ventilation. This single chamber system measures transthoracic impedance between the tip electrode of a standard bipolar lead and the pulse generator case. Low amplitude current pulses (1 mA for 15 microseconds) are generated each 50 msec between the the ring electrode and the case. In the adaptive mode, the pulse generator calculates a rate response factor or slope after maximal exercise. This slope, which describes the relationship between pacing rate and minute ventilation together with the pacing rate limits are the only programmable rate responsive features. Minute ventilation rate responsive systems have been implanted in 12 patients (8 females, 4 males), of mean age 63 years. Indications were His bundle ablation (6), acquired complete heart block (4), and sick sinus syndrome (2). At post-implant exercise testing, pacing rate rose within the first minute. Peak rate and time to upper rate were dependent on workload. After exercise, pacing rate remained at peak for up to 2 minutes before a gradual fall to resting rate. Comparative studies of the minute ventilation and the activity sensor pacing systems in the same patients confirmed that the minute ventilation system more closely parallels normal sinus response to activity. The minute ventilation rate responsive pacing system is simple to programme, no special lead is required and the system is highly physiologic.

The porous titanium steroid eluting electrode: a double blind study assessing the stimulation threshold effects of steroid

A transvenous pacing lead with a porous electrode which slowly elutes the steroid, dexamethasone sodium phosphate, has been developed. Previous investigations show low and constant stimulation thresholds persisting over at least the first two years post-implantation. As it is not known whether this low threshold results from the steroid or electrode configuration, a double blind study was designed to compare the same electrode configuration with and without steroid over a 2-year follow-up period. There were ten patients in each group with similar age, sex, indications for pacing and implantation data. Regular measurements of postoperative pulse duration thresholds were performed using a customized VVIM pulse generator programmed to 1.5 V output. For the first two days post-implantation, there were no statistical differences in the pulse duration thresholds between the two pacing leads. From 2 weeks to 2 years the pulse duration thresholds for the steroid leads remained almost constant, whereas the leads without steroid showed a typical rise. The difference in pulse duration thresholds between the two groups of leads from two weeks onwards confirmed that it was the steroid rather than the electrode configuration which prevented the rise in chronic stimulation threshold.

Comparison of lead complications with polyurethane tined, silicone rubber tined, and wedge tip leads: clinical experience with 822 ventricular endocardial lads

Lead-related complications have been prospectively studied for 602 unipolar tined endocardial ventricular pacemaker leads implanted over a five-year period. No differences were noted in overall complication rates between 238 polyurethane insulated leads (4.2%) and 364 silicone rubber insulated leads (3.6%). Comparing the total series of 602 tined leads to a retrospective survey of 220 wedge tip leads, a marked reduction in dislodgements (0.3% vs. 7.7%, P less than 0.001) and reoperations (2.0% vs 15.0%, P less than 0.001) was found using tined leads. We conclude that tined ventricular leads are far superior to wedge tip leads with respect to lead complications.

Patient initiated implantable pacemakers for paroxysmal supraventricular tachycardia

Seven patients with recurrent paroxysmal supraventricular tachycardia (PSVT) resistant to standard drug therapy were treated with patient initiated implantable pacemakers. All patients had required frequent hospital admissions and cardioversions prior to pacemaker implantation. Two patients had Wolff-Parkinson-White (WPW) syndrome on their surface ECGs and five patients had no ECG evidence of preexcitation. All patients had detailed electrophysiological studies. Three patients had junctional tachycardia, one patients had reciprocating atrial tachycardia and in three, including one with normal surface ECG, retrogradely conducting accessory atrio-ventricular connections (AAVC) formed a part of the tachycardia circuit. Initiation and termination of tachycardia were re-checked at subsequent studies. On the basis of these studies, two patients with WPW syndrome had right ventricular endocardial leads and custom-built, magnet actuated pacemakers capable of delivering right ventricular coupled stimuli at fixed, present intervals of 200 and 400 ms. Both these pacemakers provided inconsistent reversions and proved unsatisfactory. In the remaining five patients, a unipolar tined J-shaped right atrial (RA) lead (Medtronic 6991) and a radiofrequency (RF) receiver (Medtronic 5998T) were implanted and enabled patients to overdrive ranged from 14 to 20 months. Several episodes of PSVT have been consistently reverted and none have required hospitalisation or cardio-version. Two patients had transient atrial fibrillation following the application of RF pacemaker. Three have required no antiarrhythmic drugs and in two the drug therapy has been greatly reduced and simplified. The Medtronic 6991 lead provided satisfactory RA stimulation without dislodgement. In carefully selected patients with PSVT, RF pacemakers provide a useful mode of treatment.

The refurbished pulse generator

With the advent of long-life lithium pulse generators, normally functioning pulse generators with a potential life of more than five years have been removed from patients and become available for re-implantation. Although pulse generator refurbishing is widely employed, the practice has not been accepted in the United States. At The Royal Melbourne Hospital, all lithium pulse generators removed because of patient death or other causes were washed in a quaternary ammonium compound and soaked in formaldehyde. Pulse generators were than electronically tested and, if within specification, were made available for re-implantation. Pulse generators were then washed under sterile conditions in distilled water and gas-sterilized with ethylene oxide. Between 1975 and 1978 (48 months), 600 pulse generators were implanted and 93 pulse generators removed. There were 56 deaths, 22 cases of pre-erosion, erosion, or infection and 15 elective removals either due to lead problems or impending power source depletion. Eight-three (89%) pulse generators were refurbished (14% of total implants). This included 12 pulse generators refurbished on two occasions. Ten pulse generators were returned to manufacturers, seven because of impending power source depletion, two with suspected electronic faults, and one with a damaged case. Two complications occurred in patients with refurbished pulse generators. An infective process present with the previous pulse generator spread to a new pocket. The other pulse generator was removed 35 months post second implantation because of impending power source depletion. Primary infection or unusual tissue reactions did not occur. Pulse generator refurbishing as described was found to be a safe and economic procedure.

The small-tined pacemaker lead--absence of dislodgement

The Medtronic 6961 unipolar transvenous ventricular lead has four symmetrically placed, small tines that protrude backward just proximal to the tip, and are designed to become entrapped beneath or between right ventricular trabeculae. One hundred leads were implanted. Initially, the leads were more difficult to position at the right ventricular apex as the tines tended to anchor on intracardiac structures. This was overcome by rotating the lead. The time of negotiating the lead from right atrium to right ventricular apex averaged 3.1 minutes for all leads. The first 20 procedures averaged 4.2 minutes and the last 20 averaged 2.1 minutes. In this latter group, 11 of the 20 passages took 60 seconds or less. Once adequate positioning was obtained, the lead was retracted using slight tension to demonstrate tip entrapment. There were no lead dislodgements. Eight deaths occurred following institution of pacing and lead dislodgement was not detected in any of these cases. Four patients had complications associated with pacing, two transient diaphragmatic pacing not requiring reoperation, one right ventricular perforation and one raised threshold with intermittent failure of pacing without lead perforation or dislodgement. Because of the absence of dislodgement, this lead appears to have significant advantages over conventional leads.

Mitral valve prolapse

Mitral valve prolapse is a relatively common condition in the general population. The syndrome appears more common in females, and is often associated with a family history. Patients may be asymptomatic or may present with a variety of symptoms ranging from mild chest aches and anxiety to severe angina-like chest pain, palpitations and dizziness. The common auscultatory features include mid-systolic clicks and a late systolic murmur, either alone or in combination. The wide spectrum of symptoms and signs may be explained by ventriculovalvular disproportion, where either the ventricle is too small for the valve, or the valve is too large for the ventricle. The long-term prognosis is very good; severe mitral regurgitation can occasionally develop, but both sudden death and bacterial endocarditis are rare. No treatment is required for asymptomatic patients, beyond antibiotic cover for dental procedures and surgery.

Systolic honks in young children

Three children with loud systolic honks were studied noninvasively with phonocardiography and echocardiography. It was shown that the precordial honk, like the late systolic mitral murmur and the clicking apical systolic sound, is part of a continuum of auscultatory sounds that result from a defect of mitral valve support and are classified under the general heading of mitral valve prolapse syndrome. Prolapse of one or both of the mitral valve leaflets is believed to cause the characteristic auscultatory findings of click, murmur or honk. The timing of these sounds in systole varies with different physiologic or pharmacologic maneuvers. Variations in the onset of prolapse are associated with changes in left ventricular end-diastolic dimensions.

Heart motion video tracking

Images